Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

Eumovate Cream clobetasone butyrate

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Dermovate Scalp Application clobetasol propionate

Eumovate Ointment clobetasone butyrate

Dermovate Scalp Application clobetasol propionate

Dermovate Ointment clobetasol propionate

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

Package Leaflet: Information for the User

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

What is in this leaflet 1. What Dalacin Cream is and what it is used for

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

Dermovate Ointment clobetasol propionate

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

Daktacort 2% / 1% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

1 What Gyno-Daktarin cream is and what it is used for

PATIENT INFORMATION LEAFLET. Timodine Cream

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

Dalacin V Cream Clindamycin phosphate

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

Retin-A 0.05% w/w cream

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

DP Fusidic Acid Cream

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Hair Loss Treatment Regular Strength (Minoxidil)

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

ISOTREX GEL Isotretinoin 0.05% w/w

ACETOCAUSTIN 0,5 ml, Cutaneous solution

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

A guide for patients who have been prescribed Stelara

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

O N C E A DAY. In this leaflet FOR WOMEN

Occlusal 26%w/w cutaneous solution salicylic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

COLORADO AESTHETIC CENTER

WOMEN'S Regaine EXTRA STRENGTH

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

Psoralen Tablets (Methoxypsoralen)

CONSUMER MEDICINE INFORMATION

EUMOVATE Clobetasone butyrate 0.05% w/w cream

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

SIGMACORT cream and ointment

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

Patient Information Leaflet. Dermal Filler

Information PROPECIA Finasteride 1mg Tablet

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

PHARMACY PRACTICE I LAB PHCY 280L

Daivobet 50/500 gel Dye-vo-bet

MyStelara. For patients who have been prescribed Stelara

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin Kabi 150 mg/ml solution for injection. Clindamycin

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA.

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

v MM 130.2MM FOR WOME N O N C E A D AY

Administering ORENCIA (abatacept): Your Step-by-Step Guide

Cosmetic Surgery: Eyelid Surgery (Blepharoplasty)

FACT SHEET: ISOTRETINOIN INFORMATION FOR PATIENTS

The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen

SELECT 1 DAY CONTACT LENS

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

z.one concept zoneconceptofficial z_one_concept zoneconcept z-oneconcept.com

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

Pre Treatment Advice and Procedures

Information for Patients with Dry Eye

Skin Care During Radiation Therapy

NORTH STAR NURSERY AND HOLIDAY CLUB SUN PROTECTION POLICY

For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory OILATUM EMOLLIENT. Light Liquid Paraffin Emollient

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

Information for Patients. Marginal Ulcer

Brow and Beauty Bar - Permanent Makeup

Skin Reactions from Radiation Treatments

Instructions for use. Ixekizumab

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

Transcription:

Package leaflet: Information for the user Fredomat 40 microgram/ml oogdruppels, oplossing Travoprost Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What <TRAVOPROST> is and what it is used for 2. What you need to know before you use <TRAVOPROST> 3. How to use <TRAVOPROST> 4. Possible side effects 5. How to store <TRAVOPROST> 6. Contents of the pack and other information 1. What <TRAVOPROST> is and what it is used for <TRAVOPROST> contains travoprost, one of a group of medicines called prostaglandin analogues. It works by reducing the pressure in the eye. It may be used on its own or with other drops e.g. beta-blockers, which also reduce pressure. <TRAVOPROST> is used to reduce high pressure in the eye in adults. This pressure can lead to an illness called glaucoma. 2. What you need to know before you use <TRAVOPROST> Do not use <TRAVOPROST> if you are allergic to travoprost or any of the other ingredients of this medicine (listed in section 6). Ask your doctor for advice if this applies to you. Warnings and precautions Talk to your doctor or, pharmacist before using <TRAVOPROST> <TRAVOPROST> may increase the length, thickness, colour and/or number of your eyelashes. Changes in the eyelids including unusual hair growth or in the tissues around the eye have also been observed. <TRAVOPROST> may change the colour of your iris (the coloured part of your eye). This change may be permanent. A change in the colour of the skin around the eye may also occur. If you have had cataract surgery, talk to your doctor before you use <TRAVOPROST> 1

If you have current or previous history of an eye inflammation (iritis and uveitis), talk to your doctor before you use <TRAVOPROST> <TRAVOPROST> may rarely cause breathlessness or wheezing or increase the symptoms of asthma. If you are concerned about changes in your breathing pattern when using <TRAVOPROST> advise your doctor as soon as possible. Travoprost may be absorbed through the skin. If any of the medicinal product comes into contact with the skin, it should be washed off straight away. This is especially important in women who are pregnant or are attempting to become pregnant. If you wear soft contact lenses, do not use the drops with your lenses in. After using the drops wait 15 minutes before putting your lenses back in. Children and adolescents Use of <TRAVOPROST>is not recommended to those under 18 years of age. Other medicines and <TRAVOPROST> Tell your doctor or pharmacist if you are taking, have recently taken or used any other medicines. Pregnancy, breast-feeding and fertiliy Do not use <TRAVOPROST> if you are pregnant. If you think that you may be pregnant speak with your doctor right away. If you could become pregnant you must use adequate contraception whilst you use <TRAVOPROST>. Do not use <TRAVOPROST> if you are breast feeding, <TRAVOPROST> may get into your milk. Ask your doctor for advice before taking any medicine. Driving and using machines You may find that your vision is blurred for a time just after you use <TRAVOPROST>. Do not drive or use machines until this has worn off. <TRAVOPROST> contains macrogolglycerol hydroxystearate and propylene glycol which may cause skin reactions and irritation. 3. How to use <TRAVOPROST> Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is One drop in the affected eye or eyes, once a day - in the evening. Only use <TRAVOPROST> in both eyes if your doctor told you to. Use it for as long as your doctor told you to. Only use <TRAVOPROST> for dropping in your eyes. 2

Immediately before using a bottle for the first time, write the date of opening on the carton in the space provided Wash your hands Twist off the cap After cap is removed, if tamper evident snap collar is loose, remove before using the product. Hold the bottle, pointing down, between your thumb and fingers Tilt your head back. Pull down your eyelid with a clean finger, until there is a pocket between the eyelid and your eye. The drop will go in here. Bring the bottle tip close to the eye. Use a mirror if it helps. Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops. Gently squeeze the bottle to release one drop of <TRAVOPROST> at a time After using <TRAVOPROST>, keep the eyelid closed, apply gentle pressure by pressing a finger into the corner of your eye, by the nose for at least 1 minute. This helps to stop <TRAVOPROST> getting into the rest of the body. If you use drops in both eyes, repeat the steps for your other eye. Close the bottle cap firmly immediately after use Only use one bottle at a time. If a drop misses your eye, try again. If you are using other eye preparations such as eye drop or eye ointment, wait for at least 5 minutes between putting in <TRAVOPROST> and the other eye preparations. If you use more <TRAVOPROST> than you should Rrinse all the medicine out with warm water. Don t put in any more drops until it s time for your next regular dose. If you forget to use <TRAVOPROST> Continue with the next dose as planned. Do not use a double dose to make up for a forgotten dose. Never use more than one drop in the affected eye(s) in a single day. If you stop using <TRAVOPROST> Do not stop using <TRAVOPROST> without first speaking to your doctor, the pressure in your eye will not be controlled which could lead to loss of sight. If you have any further questions on the use of this medicine ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. 3

You can usually carry on using the drops, unless the side effects are serious. If you re worried, talk to a doctor or pharmacist. Do not stop taking <TRAVOPROST> without speaking to your doctor. The following side effects have been seen with travoprost containing eye drops Very common side effects: may affect more than 1 in 10 people Effects in the eye: eye redness Common side effects: may affect up to 1 in 10 people Effects in the eye: changes in the colour of the iris (coloured part of the eye), eye pain, eye discomfort, dry eye, itchy eye, eye irritation Uncommon side effects: may affect up to 1 in 100 people Effects in the eye: corneal disorder, eye inflammation, iris inflammation, inflammation inside the eye, eye surface inflammation with/out surface damage, sensitivity to light, eye discharge, eyelid inflammation, eyelid redness, swelling around the eye, eyelid itching, reduced vision, blurred vision, increased tear production, infection or inflammation of the conjunctiva (conjunctivitis), abnormal turning outward of the lower eyelid, clouding of the eye, eyelid crusting, growth of eyelashes, discolouration of the eyelashes, tired eyes. General side effects: increased allergic symptoms, headache, dizziness, irregular heart beat, shortness of breath, asthma, stuffy nose, throat irritation, darkening of skin around the eye (s), skin darkening, abnormal hair texture, excessive hair growth. Rare: may affect up to 1 in 1,000 people Effects in the eye: perception of flashing lights, eczema of the eyelids, eye swelling, halo vision, decreased eye sensation, inflammation of the glands of the eyelids, pigmentation inside the eye, increase in pupil size, change in the texture of the eyelashes. General side effects: eye viral infection, bad taste, irregular or decreased heart rate, increased or decreased blood pressure, cough, voice changes, gastrointestinal discomfort or ulcer, constipation, dry mouth, redness or itching of the skin, rash, hair colour change, loss of eyelashes, musculoskeletal pain, generalised weakness. Not known: frequency cannot be estimated from the available data Effects in the eye: inflammation of the back of the eye, eyes appear more inset. General side effects: depression, anxiety, sensation of false movement, ringing in ears, chest pain, worsening of asthma, diarrhea, abdominal pain, nausea, itching, abnormal hair growth, joint pain, painful or involuntary urination, increase in prostate cancer marker. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V.. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store <TRAVOPROST> Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and the box after Exp. The expiry date refers to the last day of the month. 4

This medicine does not require any special temperature storage conditions. Keep the bottle in the outer carton in order to protect from light. You must throw away the bottle 4 weeks after you first opened it, to prevent infections, and use a new bottle. Write down the date you opened it in the space on the carton box. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What <TRAVOPROST> contains - The active substance is travoprost 40 micrograms/ml. - The other ingredients are: Polyquaternium-1, macrogolglycerol hydroxystearate 40, propylene glycol (E1520), sodium chloride, boric acid (E284), mannitol (E421) and purified water. Sodium hydroxide or hydrochloric acid for ph adjustment. What <TRAVOPROST> looks like and contents of the pack <TRAVOPROST> is a clear, colourless solution, practically free of particles in a pack containing either 1, 3 or 6 plastic bottles each with a screw cap. Each bottle contains 2.5 ml solution. Not all pack sizes may be marketed. Marketing Authorisation Holder: Centrafarm B.V. Nieuwe Donk 3 4879 AC Etten-Leur Nederland Manufacturer: S.C. ROMPHARM COMPANY S.R.L. Eroilor Street, no. 1A Otopeni 075100, Ilov. Roemenië STADA Arzneimittel AG Stadastrasse 2 18 61118 Bad Vilbel Duitsland STADA Arzneimittel GmbH Muthgasse 36/2 1190 Wenen Oostenrijk In het register ingeschreven onder Fredomat 40 microgram/ml oogdruppels, oplossing RVG 114964 This medicinal product is authorised in the Member States of the EEA under the following names: België: Fredomat 40 microgram/ml oogdruppels, oplossing Denemarken: Fredomat 40 mikrogram/ml øjendråber, opløsning Duitsland: Fredomat 40 Mikrogramm/ml Augentropfen Finland: Fredomat 40 mikrogrammaa/ml silmätipat, liuos Italie: Fredomat 40 microgrammi/ml collirio, soluzione 5

Luxemburg: Fredomat microgrammes/ml collyre en solution Nederland: Fredomat 40 microgram/ml oogdruppels, oplossing Oostenrijk: Fredomat 40 Mikrogramm/ml Augentropfen Spanje: Fredomat 40 microgramos/ml colirio en solución Portugal: Fredomat 40 microgramas/ml colírio, solução Tsjechië: Fredomat 40 mikrogramů/ml oční kapky, roztok Zweden: Fredomat 40 mikrogram/ml ögondroppar, lösning Deze bijsluiter is voor het laatst goedgekeurd in augustus 2016 6